Douglas K. Logan
Douglas K. Logan publishes mostly in Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery, on topics such as Diabetes Treatment and Management, Antiplatelet Therapy and Cardiovascular Diseases and Lipoproteins and Cardiovascular Health.
- World rank
- #1,396,393 of 7,710,434 ranked researchers
- Rank in United States
- #441,107 of 1,627,098
- Works
- 21
- Citations
- 1.3k
- Citations per work
- 63.8
What does Douglas K. Logan research?
Douglas K. Logan's work is mostly in Medicine (73%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1572.7%
- Medicine1572.7%
- Everything else523.7%
- Life Sciences13.6%
- 1Endocrinology, Diabetes and Metabolism26% of their works
- 2Cardiology and Cardiovascular Medicine24% of their works
- 3Surgery14% of their works
- 4Pharmacology6% of their works
- 5Molecular Biology4% of their works
- 6Epidemiology4% of their works
Research topics
- Diabetes Treatment and Management
- Antiplatelet Therapy and Cardiovascular Diseases
- Lipoproteins and Cardiovascular Health
- Diabetes Management and Research
- Metabolism, Diabetes, and Cancer
- Lipid metabolism and disorders
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Inflammatory mediators and NSAID effects
Which keywords describe Douglas K. Logan's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Cardiovascular Outcomes, Type 2 Diabetes, Cardiovascular Disease, Diabetes, Aspirin and Cholesterol-lowering.
- Obesity
- Lipoprotein Lipase
- Inflammation
- ANGPTL3
- Metabolic Syndrome
- Continuous Glucose Monitoring
- Statins
- Cholesterol-lowering
- Diabetes
- Type 2 Diabetes
- Insulin Therapy
- Glycemic Control
- Cardiovascular Outcomes
- Cardiovascular Disease
- Aspirin
- Clopidogrel
- Atherosclerosis
- Hypoglycemia
- AMP-Activated Protein Kinase
- Cyclooxygenase-2 Inhibitors
- Insulin Resistance
- Metformin
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Glycemic Control112 topics
- Insulin Therapy112 topics
- Cardiovascular Outcomes71 topic
- Type 2 Diabetes71 topic
- Cardiovascular Disease62 topics
- Diabetes62 topics
- Aspirin51 topic
- Cholesterol-lowering51 topic
- Clopidogrel51 topic
- Statins51 topic
- Atherosclerosis42 topics
- Continuous Glucose Monitoring41 topic
- Hypoglycemia41 topic
- Metabolic Syndrome42 topics
- AMP-Activated Protein Kinase21 topic
- ANGPTL321 topic
- Cyclooxygenase-2 Inhibitors21 topic
- Inflammation21 topic
- Insulin Resistance21 topic
- Lipoprotein Lipase21 topic
- Metformin21 topic
- Obesity21 topic
Where does Douglas K. Logan work?
Douglas K. Logan's main affiliation in the publication record is Medpace (United States), United States.
How many publications and citations does Douglas K. Logan have?
OpenAlex counts 21 works and 1,339 citations for Douglas K. Logan, an h-index of 10, ranking #1,396,393 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Douglas K. Logan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.